NCT02462330 - Administration of Mesenchymal Stem Cells in Patients With Chronic Ischemic Cardiomyopathy (MESAMI2) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 19, 2016

Primary Completion Date

December 19, 2022

Study Completion Date

December 19, 2022

Conditions

Chronic Myocardial Ischemia

Interventions

DRUG

Autologous MSC from bone marrow

After bone-marrow aspiration by an authorized person, MSCs were isolated and cultured during 17±2 days by the French Blood Establishment. Then, patients receive intramyocardial injections of MSCs using the electromechanical NOGA-XP system.

DRUG

Placebo comparator

injections of human albumin

Trial Locations (6)

31059

Cardiology Department of Rangueil Hospital - Rangueil Hospital, Toulouse

38043

University hospital of Grenoble, Grenoble

44093

University hospital of Nantes, Nantes

59037

University hospital of Lille, Lille

75651

University hospital of Pitié-Salpêtrière, Paris

94010

University hospital of Henri Mondor, Créteil

All Listed Sponsors

lead

University Hospital, Toulouse

OTHER